Literature DB >> 17600184

Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.

Andrew D Ferguson1, Brian M McKeever, Shihua Xu, Douglas Wisniewski, Douglas K Miller, Ting-Ting Yamin, Robert H Spencer, Lin Chu, Feroze Ujjainwalla, Barry R Cunningham, Jilly F Evans, Joseph W Becker.   

Abstract

Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4.0 and 4.2 angstrom resolution, respectively. The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis. This structural information provides a platform for the development of therapeutics for respiratory and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600184     DOI: 10.1126/science.1144346

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  70 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 2.  Structures of membrane proteins.

Authors:  Kutti R Vinothkumar; Richard Henderson
Journal:  Q Rev Biophys       Date:  2010-02       Impact factor: 5.318

Review 3.  Location, location, location: compartmentalization of early events in leukotriene biosynthesis.

Authors:  Marcia E Newcomer; Nathaniel C Gilbert
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

4.  Leukotriene Inhibitors in Sinusitis.

Authors:  John W Steinke; Joshua L Kennedy
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

5.  Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

Authors:  Swarup K Chakrabarti; Yeshao Wen; Anca D Dobrian; Banumathi K Cole; Qian Ma; Hong Pei; Michael D Williams; Melissa H Bevard; George E Vandenhoff; Susanna R Keller; Jiali Gu; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

6.  Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors.

Authors:  Shihua Xu; Brian M McKeever; Douglas Wisniewski; Douglas K Miller; Robert H Spencer; Lin Chu; Feroze Ujjainwalla; Ting Ting Yamin; Jilly F Evans; Joseph W Becker; Andrew D Ferguson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-30

Review 7.  Vertebrate membrane proteins: structure, function, and insights from biophysical approaches.

Authors:  Daniel J Müller; Nan Wu; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2008-03-05       Impact factor: 25.468

8.  The nuclear membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Phillip B Jones; Angela M Bair; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Douglas Wisniewski; John Menke; Jilly F Evans; Bradley T Hyman; Brian Bacskai; Mei Chen; David M Lee; Boris Nikolic; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

9.  GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae.

Authors:  David Drew; Simon Newstead; Yo Sonoda; Hyun Kim; Gunnar von Heijne; So Iwata
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 10.  Influences of membrane mimetic environments on membrane protein structures.

Authors:  Huan-Xiang Zhou; Timothy A Cross
Journal:  Annu Rev Biophys       Date:  2013-03-01       Impact factor: 12.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.